The rising interest in GLP-1 drugs for metabolic conditions has sparked a debate about delivery routes : skin-applied devices versus tablets . Usually , GLP-1 therapies were exclusively available in https://ihannauylx266899.qowap.com/99999470/glp-1-skin-applications-vs-oral-medications-is-right-for-the-patient